{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:23:53Z","timestamp":1741238633723,"version":"3.38.0"},"reference-count":14,"publisher":"JLE","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"am","delay-in-days":384,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.nephro.2021.10.008","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T12:21:46Z","timestamp":1656591706000},"page":"278-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u00c9tat des lieux sur l\u2019hyperkali\u00e9mie chronique persistante en France\u00a0: consensus d\u2019experts par une approche Delphi"],"prefix":"10.1684","volume":"18","author":[{"given":"Patrick","family":"Rossignol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Halimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Bataille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Juillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Thervet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Choukroun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2021.10.008_bib0075","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ckj\/sfz129","article-title":"Recurrent hyperkalaemia management and use of renin-angiotensin-aldosterone system inhibitors: a European multi-national targeted chart review","volume":"13","author":"Rossignol","year":"2019","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nephro.2021.10.008_bib0080","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/CIRCULATIONAHA.117.030576","article-title":"Long-term potassium monitoring and dynamics in heart failure and risk of mortality","volume":"137","author":"N\u00fa\u00f1ez","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.nephro.2021.10.008_bib0085","doi-asserted-by":"crossref","first-page":"e017087","DOI":"10.1161\/JAHA.120.017087","article-title":"Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hyperkalemia","volume":"9","author":"Krogager","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.nephro.2021.10.008_bib0090","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/ejhf.1793","article-title":"Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222\u00a0chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry","volume":"22","author":"Rossignol","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.nephro.2021.10.008_bib0095","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/00015385.2020.1748346","article-title":"The importance of developing hyperkalaemia in heart failure during long-term follow-up","volume":"76","author":"Martens","year":"2021","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.nephro.2021.10.008_bib0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.JAA.0000458856.92020.1e","article-title":"Hyperkalemia and potential pitfalls of sodium polystyrene sulfonate","volume":"28","author":"Nguyen","year":"2015","journal-title":"JAAPA"},{"key":"10.1016\/j.nephro.2021.10.008_bib0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.phrs.2016.07.032","article-title":"Potassium lowering agents: recommendations for physician and patient education, treatment reappraisal, and serial monitoring of potassium in patients with chronic hyperkalemia","volume":"118","author":"Pitt","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.nephro.2021.10.008_bib0110","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/ehf2.12834","article-title":"Hyperkalaemia and hypokalaemia outpatient management: a survey of 500\u00a0French general practitioners","volume":"7","author":"Abensur Vuillaume","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.nephro.2021.10.008_bib0115","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.eujim.2015.07.002","article-title":"Delphi methodology in health research: how to do it?","volume":"7","author":"Trevelyan","year":"2015","journal-title":"Eur J Integr Med"},{"key":"10.1016\/j.nephro.2021.10.008_bib0120","first-page":"S10","article-title":"Expert panel recommendations for the identification and management of hyperkalemia and role of patiromer in patients with chronic kidney disease and heart failure","volume":"23","author":"Rafique","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.nephro.2021.10.008_bib0125","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40620-019-00617-y","article-title":"Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology","volume":"32","author":"Bianchi","year":"2019","journal-title":"J Nephrol"},{"key":"10.1016\/j.nephro.2021.10.008_bib0130","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/ehjcvp\/pvy015","volume":"4","author":"Rosano","year":"2018","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.nephro.2021.10.008_bib0135","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/ejhf.1531","article-title":"Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Seferovic","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"Suppl","key":"10.1016\/j.nephro.2021.10.008_bib0070","doi-asserted-by":"crossref","first-page":"A48","DOI":"10.1093\/eurheartj\/suy032","article-title":"A new area for the management of hyperkalaemia with potassium binders: clinical use in nephrology","volume":"21","author":"Rossignol","year":"2019","journal-title":"Eur Heart J"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S176972552100568X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S176972552100568X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2021.10.008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:09:15Z","timestamp":1741190955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S176972552100568X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S176972552100568X"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2021.10.008","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9tat des lieux sur l\u2019hyperkali\u00e9mie chronique persistante en France\u00a0: consensus d\u2019experts par une approche Delphi","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2021.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}